Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7914 |
Intermediate Similarity |
NPD4478 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD7733 |
Phase 2 |
0.7517 |
Intermediate Similarity |
NPD7622 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD7448 |
Suspended |
0.7179 |
Intermediate Similarity |
NPD6240 |
Phase 3 |
0.7163 |
Intermediate Similarity |
NPD1323 |
Discontinued |
0.7019 |
Intermediate Similarity |
NPD6611 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD7579 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD4705 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD7254 |
Discontinued |
0.6867 |
Remote Similarity |
NPD5653 |
Discontinued |
0.6853 |
Remote Similarity |
NPD851 |
Approved |
0.6853 |
Remote Similarity |
NPD853 |
Approved |
0.6853 |
Remote Similarity |
NPD4674 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD3806 |
Clinical (unspecified phase) |
0.6797 |
Remote Similarity |
NPD2754 |
Discontinued |
0.6759 |
Remote Similarity |
NPD4660 |
Discontinued |
0.6752 |
Remote Similarity |
NPD7541 |
Clinical (unspecified phase) |
0.673 |
Remote Similarity |
NPD4461 |
Discontinued |
0.6628 |
Remote Similarity |
NPD4645 |
Clinical (unspecified phase) |
0.6607 |
Remote Similarity |
NPD1999 |
Phase 3 |
0.6607 |
Remote Similarity |
NPD2000 |
Phase 3 |
0.6594 |
Remote Similarity |
NPD813 |
Approved |
0.6577 |
Remote Similarity |
NPD5836 |
Discontinued |
0.6575 |
Remote Similarity |
NPD1025 |
Discontinued |
0.6566 |
Remote Similarity |
NPD8001 |
Phase 3 |
0.65 |
Remote Similarity |
NPD2980 |
Phase 2 |
0.6494 |
Remote Similarity |
NPD2413 |
Phase 2 |
0.6488 |
Remote Similarity |
NPD7744 |
Clinical (unspecified phase) |
0.6481 |
Remote Similarity |
NPD3482 |
Approved |
0.6481 |
Remote Similarity |
NPD6768 |
Approved |
0.6478 |
Remote Similarity |
NPD7192 |
Discontinued |
0.6478 |
Remote Similarity |
NPD5227 |
Clinical (unspecified phase) |
0.6474 |
Remote Similarity |
NPD3850 |
Clinical (unspecified phase) |
0.6467 |
Remote Similarity |
NPD1727 |
Approved |
0.645 |
Remote Similarity |
NPD4042 |
Phase 2 |
0.645 |
Remote Similarity |
NPD4045 |
Phase 2 |
0.645 |
Remote Similarity |
NPD4507 |
Discontinued |
0.6438 |
Remote Similarity |
NPD4077 |
Clinical (unspecified phase) |
0.6438 |
Remote Similarity |
NPD6358 |
Phase 2 |
0.6433 |
Remote Similarity |
NPD6075 |
Approved |
0.6433 |
Remote Similarity |
NPD6076 |
Approved |
0.6429 |
Remote Similarity |
NPD1387 |
Phase 1 |
0.6419 |
Remote Similarity |
NPD7679 |
Phase 2 |
0.641 |
Remote Similarity |
NPD2918 |
Clinical (unspecified phase) |
0.641 |
Remote Similarity |
NPD2919 |
Clinical (unspecified phase) |
0.6409 |
Remote Similarity |
NPD8069 |
Phase 3 |
0.6407 |
Remote Similarity |
NPD1890 |
Clinical (unspecified phase) |
0.6405 |
Remote Similarity |
NPD3550 |
Clinical (unspecified phase) |
0.6405 |
Remote Similarity |
NPD3547 |
Approved |
0.6405 |
Remote Similarity |
NPD3549 |
Approved |
0.6402 |
Remote Similarity |
NPD4043 |
Approved |
0.6402 |
Remote Similarity |
NPD4046 |
Approved |
0.6402 |
Remote Similarity |
NPD3481 |
Approved |
0.64 |
Remote Similarity |
NPD6839 |
Clinical (unspecified phase) |
0.64 |
Remote Similarity |
NPD1217 |
Clinical (unspecified phase) |
0.6392 |
Remote Similarity |
NPD6740 |
Clinical (unspecified phase) |
0.6375 |
Remote Similarity |
NPD5004 |
Approved |
0.6375 |
Remote Similarity |
NPD6817 |
Clinical (unspecified phase) |
0.6369 |
Remote Similarity |
NPD8362 |
Clinical (unspecified phase) |
0.6364 |
Remote Similarity |
NPD6792 |
Phase 3 |
0.6364 |
Remote Similarity |
NPD2634 |
Clinical (unspecified phase) |
0.6358 |
Remote Similarity |
NPD6806 |
Phase 1 |
0.6357 |
Remote Similarity |
NPD1386 |
Phase 1 |
0.6348 |
Remote Similarity |
NPD2461 |
Phase 1 |
0.6346 |
Remote Similarity |
NPD4549 |
Discontinued |
0.6346 |
Remote Similarity |
NPD2909 |
Phase 3 |
0.6346 |
Remote Similarity |
NPD2908 |
Phase 3 |
0.634 |
Remote Similarity |
NPD6041 |
Phase 1 |
0.634 |
Remote Similarity |
NPD3355 |
Approved |
0.634 |
Remote Similarity |
NPD3356 |
Approved |
0.6338 |
Remote Similarity |
NPD1765 |
Approved |
0.6338 |
Remote Similarity |
NPD1767 |
Approved |
0.6338 |
Remote Similarity |
NPD1763 |
Approved |
0.6338 |
Remote Similarity |
NPD1761 |
Approved |
0.6338 |
Remote Similarity |
NPD1766 |
Approved |
0.6323 |
Remote Similarity |
NPD1321 |
Clinical (unspecified phase) |
0.6323 |
Remote Similarity |
NPD3244 |
Pre-registration |
0.6323 |
Remote Similarity |
NPD3245 |
Phase 3 |
0.6319 |
Remote Similarity |
NPD2010 |
Phase 3 |
0.6319 |
Remote Similarity |
NPD1222 |
Discontinued |
0.6316 |
Remote Similarity |
NPD1124 |
Approved |
0.6316 |
Remote Similarity |
NPD1123 |
Approved |
0.6313 |
Remote Similarity |
NPD5480 |
Clinical (unspecified phase) |
0.6307 |
Remote Similarity |
NPD6786 |
Discontinued |
0.6289 |
Remote Similarity |
NPD441 |
Approved |
0.6286 |
Remote Similarity |
NPD1795 |
Discontinued |
0.6277 |
Remote Similarity |
NPD5554 |
Approved |
0.6275 |
Remote Similarity |
NPD3624 |
Phase 2 |
0.6271 |
Remote Similarity |
NPD3305 |
Discontinued |
0.6265 |
Remote Similarity |
NPD7602 |
Clinical (unspecified phase) |
0.6265 |
Remote Similarity |
NPD8239 |
Clinical (unspecified phase) |
0.6258 |
Remote Similarity |
NPD2056 |
Discontinued |
0.6241 |
Remote Similarity |
NPD2648 |
Phase 3 |
0.6241 |
Remote Similarity |
NPD2193 |
Phase 2 |
0.6241 |
Remote Similarity |
NPD2171 |
Approved |
0.6236 |
Remote Similarity |
NPD6193 |
Clinical (unspecified phase) |
0.6235 |
Remote Similarity |
NPD4214 |
Discontinued |
0.6235 |
Remote Similarity |
NPD6342 |
Discontinued |
0.6235 |
Remote Similarity |
NPD7745 |
Clinical (unspecified phase) |
0.623 |
Remote Similarity |
NPD7190 |
Clinical (unspecified phase) |
0.6226 |
Remote Similarity |
NPD2846 |
Clinical (unspecified phase) |
0.622 |
Remote Similarity |
NPD3434 |
Clinical (unspecified phase) |
0.6214 |
Remote Similarity |
NPD1796 |
Phase 3 |
0.6214 |
Remote Similarity |
NPD4737 |
Phase 2 |
0.6196 |
Remote Similarity |
NPD4158 |
Clinical (unspecified phase) |
0.6196 |
Remote Similarity |
NPD8241 |
Phase 2 |
0.619 |
Remote Similarity |
NPD8165 |
Discontinued |
0.619 |
Remote Similarity |
NPD7088 |
Discontinued |
0.6188 |
Remote Similarity |
NPD5840 |
Discontinued |
0.6188 |
Remote Similarity |
NPD4503 |
Phase 2 |
0.6188 |
Remote Similarity |
NPD4680 |
Discontinued |
0.6182 |
Remote Similarity |
NPD6566 |
Discontinued |
0.6174 |
Remote Similarity |
NPD2508 |
Discontinued |
0.6174 |
Remote Similarity |
NPD3551 |
Approved |
0.617 |
Remote Similarity |
NPD5630 |
Phase 1 |
0.6168 |
Remote Similarity |
NPD7575 |
Phase 3 |
0.6154 |
Remote Similarity |
NPD2962 |
Approved |
0.6154 |
Remote Similarity |
NPD2577 |
Clinical (unspecified phase) |
0.6154 |
Remote Similarity |
NPD1482 |
Clinical (unspecified phase) |
0.6154 |
Remote Similarity |
NPD2961 |
Approved |
0.6139 |
Remote Similarity |
NPD1050 |
Approved |
0.6139 |
Remote Similarity |
NPD1781 |
Discontinued |
0.6127 |
Remote Similarity |
NPD2196 |
Discontinued |
0.6127 |
Remote Similarity |
NPD4803 |
Discontinued |
0.6125 |
Remote Similarity |
NPD5581 |
Approved |
0.6124 |
Remote Similarity |
NPD5921 |
Clinical (unspecified phase) |
0.6121 |
Remote Similarity |
NPD7720 |
Phase 2 |
0.6114 |
Remote Similarity |
NPD5992 |
Approved |
0.6111 |
Remote Similarity |
NPD5780 |
Phase 2 |
0.6111 |
Remote Similarity |
NPD1677 |
Discontinued |
0.6111 |
Remote Similarity |
NPD7854 |
Phase 2 |
0.6108 |
Remote Similarity |
NPD5918 |
Discontinued |
0.6108 |
Remote Similarity |
NPD7949 |
Clinical (unspecified phase) |
0.6099 |
Remote Similarity |
NPD787 |
Suspended |
0.6095 |
Remote Similarity |
NPD6631 |
Clinical (unspecified phase) |
0.6093 |
Remote Similarity |
NPD5162 |
Approved |
0.6092 |
Remote Similarity |
NPD5660 |
Approved |
0.6092 |
Remote Similarity |
NPD5659 |
Approved |
0.6092 |
Remote Similarity |
NPD6018 |
Approved |
0.6092 |
Remote Similarity |
NPD6019 |
Approved |
0.609 |
Remote Similarity |
NPD9541 |
Approved |
0.609 |
Remote Similarity |
NPD1640 |
Clinical (unspecified phase) |
0.609 |
Remote Similarity |
NPD9539 |
Approved |
0.6087 |
Remote Similarity |
NPD1966 |
Approved |
0.6078 |
Remote Similarity |
NPD5516 |
Phase 2 |
0.6078 |
Remote Similarity |
NPD5517 |
Phase 2 |
0.6069 |
Remote Similarity |
NPD7072 |
Phase 2 |
0.6067 |
Remote Similarity |
NPD2319 |
Discontinued |
0.6062 |
Remote Similarity |
NPD7995 |
Phase 2 |
0.6059 |
Remote Similarity |
NPD4939 |
Clinical (unspecified phase) |
0.6054 |
Remote Similarity |
NPD3581 |
Discontinued |
0.6053 |
Remote Similarity |
NPD5991 |
Approved |
0.6053 |
Remote Similarity |
NPD7786 |
Discontinued |
0.6053 |
Remote Similarity |
NPD5990 |
Approved |
0.6048 |
Remote Similarity |
NPD4464 |
Clinical (unspecified phase) |
0.6048 |
Remote Similarity |
NPD3508 |
Approved |
0.6042 |
Remote Similarity |
NPD4937 |
Approved |
0.6042 |
Remote Similarity |
NPD4936 |
Approved |
0.6026 |
Remote Similarity |
NPD6408 |
Phase 1 |
0.6014 |
Remote Similarity |
NPD6588 |
Clinical (unspecified phase) |
0.6013 |
Remote Similarity |
NPD6563 |
Approved |
0.6013 |
Remote Similarity |
NPD6565 |
Approved |
0.6013 |
Remote Similarity |
NPD6564 |
Approved |
0.6013 |
Remote Similarity |
NPD9540 |
Approved |
0.6013 |
Remote Similarity |
NPD474 |
Approved |
0.6012 |
Remote Similarity |
NPD2331 |
Discontinued |
0.6012 |
Remote Similarity |
NPD7612 |
Clinical (unspecified phase) |
0.6011 |
Remote Similarity |
NPD7065 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD2192 |
Approved |
0.6 |
Remote Similarity |
NPD6655 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD2197 |
Approved |
0.6 |
Remote Similarity |
NPD5187 |
Clinical (unspecified phase) |
0.6 |
Remote Similarity |
NPD6998 |
Discontinued |
0.5988 |
Remote Similarity |
NPD6639 |
Clinical (unspecified phase) |
0.5985 |
Remote Similarity |
NPD5915 |
Approved |
0.5985 |
Remote Similarity |
NPD2811 |
Clinical (unspecified phase) |
0.5977 |
Remote Similarity |
NPD7267 |
Clinical (unspecified phase) |
0.5976 |
Remote Similarity |
NPD8125 |
Discontinued |
0.5976 |
Remote Similarity |
NPD6552 |
Clinical (unspecified phase) |
0.5969 |
Remote Similarity |
NPD6200 |
Clinical (unspecified phase) |
0.5966 |
Remote Similarity |
NPD4393 |
Approved |
0.5966 |
Remote Similarity |
NPD33 |
Approved |
0.5965 |
Remote Similarity |
NPD4942 |
Approved |
0.5963 |
Remote Similarity |
NPD4497 |
Clinical (unspecified phase) |
0.5963 |
Remote Similarity |
NPD486 |
Clinical (unspecified phase) |
0.5959 |
Remote Similarity |
NPD6834 |
Approved |
0.5944 |
Remote Similarity |
NPD1916 |
Discontinued |
0.5941 |
Remote Similarity |
NPD3510 |
Approved |
0.5941 |
Remote Similarity |
NPD6884 |
Clinical (unspecified phase) |
0.5941 |
Remote Similarity |
NPD3509 |
Approved |
0.5939 |
Remote Similarity |
NPD6294 |
Approved |
0.5939 |
Remote Similarity |
NPD6295 |
Approved |
0.5939 |
Remote Similarity |
NPD3934 |
Clinical (unspecified phase) |
0.5938 |
Remote Similarity |
NPD4342 |
Phase 2 |
0.5938 |
Remote Similarity |
NPD7828 |
Discontinued |
0.5938 |
Remote Similarity |
NPD5442 |
Approved |
0.5935 |
Remote Similarity |
NPD1104 |
Approved |
0.5926 |
Remote Similarity |
NPD6632 |
Clinical (unspecified phase) |
0.592
|
Remote Similarity |
NPD2790 |
Discontinued |